Table 1.
Characteristics of the cohort participants in CARDIIGAN (n=8296)
| Characteristics | Specifics | Missing (n) |
| Sex | Female: 2908 (35%) Male: 5388 (65%) |
0 |
| Age at baseline (years), mean (SD) |
63 (11) | 0 |
| Residence | Tyrol: 6949 (84%) Rest of Austria: 1027 (12%) Foreign: 320 (4%) |
0 |
| Height (m), mean (SD) |
1.71 (0.09) | 117 |
| Weight (kg), mean (SD) |
78.4 (14.9) | 118 |
| Smoking status | Never: 3660 (52%) Former: 1929 (27%) Current: 1495 (21%) |
1212 |
| Angina pectoris complaints | None: 3671 (44%) Stable: 2986 (36%) Unstable: 1269 (15%) Atypical: 370 (4%) |
0 |
| Myocardial infarction | None: 6523 (79%) STEMI: 459 (6%) NSTEMI: 631 (8%) MCI: 683 (8%) |
0 |
| Valvular/congenital heart disease | No: 6395 (87%) Yes: 957 (13%) |
944 |
| Cardiomyopathy | No: 3793 (86%) Yes: 594 (14%) |
3909 |
| Solid organ transplantation | No: 8128 (98%) Yes: 168 (2%) |
0 |
| Hypertension | No: 2227 (27%) Yes: 6069 (73%) |
0 |
| Diabetes mellitus | No: 6902 (83%) Yes: 1394 (17%) |
0 |
| Family history of myocardial infarction (first-degree relative: male <55 years; female <65 years) |
No: 6532 (79%) Yes: 1764 (21%) |
0 |
| Lipid-lowering medication: statin | No: 2521 (46%) Yes: 2967 (54%) |
2808 |
| Antihypertension/anti-anginal medication |
No: 1141 (20%) Yes: 4434 (80%) |
2721 |
| Total cholesterol (mg/dL), mean (SD) | 193 (45) | 585 |
| HDL cholesterol (mg/dL), mean (SD) | 54.9 (17.0) | 741 |
| LDL cholesterol (mg/dL), mean (SD) |
123 (38) | 756 |
| Triglycerides (mg/dL), median (IQR) |
126 (91–175) | 591 |
| Fibrinogen (mg/dL), median (IQR) |
367 (297–459) | 265 |
| C reactive protein (mg/dL), median (IQR) |
0.28 (0.12–0.70) | 207 |
| Prothrombin time (%), mean (SD) | 103 (13) | 151 |
| Thrombocytes (×1000 U/µL), mean (SD) | 233 (67) | 147 |
| Haemoglobin (g/dL), mean (SD) | 14.3 (2.3) | 119 |
| Creatinine (mg/dL), mean (SD) | 1.07 (0.72) | 105 |
| Gamma-glutamyltransferase (U/L), median (IQR) |
33 (21–54) | 321 |
| Uric acid (mg/dL), mean (SD) | 6.33 (1.76) | 970 |
| Urea (mg/dL), median (IQR) | 35.4 (29.1–44.4) | 248 |
| Maximum degree of stenosis | None: 2029 (25%) <50%: 1588 (20%) ≥50%–70%: 296 (4%) ≥70%: 4157 (52%) |
226 |
| Number of stents | None: 5918 (76%) 1: 1398 (18%) ≥2: 424 (5%) |
556 |
| Number of bypass | None: 7330 (94%) ≥1: 439 (6%) |
527 |
| Cause of death (up until 31 December 2013) with complete ICD-10 code | Alive: 5366 (77%) Cardiovascular death: 746 (11%) Other causes: 837 (12%) |
1347 |
CARDIIGAN, Coronary Artery disease Risk Determination In Innsbruck by diaGnostic ANgiography; HDL, high-density lipoprotein; ICD-10, International Classification of Diseases, tenth revision; LDL, low-density lipoprotein; MCI, myocardial infarction; NSDTEMI, non-ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction.